A real world study on the treatment of prostate cancer by integrated Chinese and Western medicine
Phase 1
- Conditions
- Prostate cancer
- Registration Number
- ITMCTR2200006847
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
(1)Prostate cancer diagnosed by pathology, aged 18-90 years old; (2)Advanced or metastatic diseases,with the treatment of endocrine therapy; (3)With complete clinical data such as PSA and imaging examination data, which can evaluate drug resistance and bone metastasis; (4) With survival data or follow-up information such as telephone,etc.
Exclusion Criteria
Prostate cancer patients with early stage tumors preferred for surgery or radiotherapy.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to CRPC;
- Secondary Outcome Measures
Name Time Method Overall survival;Radiographic progression-free survival;